News
ADRX-0706 has received FDA fast track designation for the treatment of metastatic or locally advanced squamous cell cervical ...
T-DXd followed by THP improved pCR in high-risk, early-stage HER2+ breast cancer in the phase 3 DESTINY-Breast11 trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback